A look at Becton Dickinson & Co’s (BDX) recent performance gives investors their first glimpse of hope.

On Monday, Becton Dickinson & Co (NYSE: BDX) was -0.87% drop from the session before settling in for the closing price of $228.49. A 52-week range for BDX has been $218.75 – $249.89.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.72%. When this article was written, the company’s average yearly earnings per share was at 9.69%. With a float of $289.52 million, this company’s outstanding shares have now reached $290.01 million.

Considering the fact that the conglomerate employs 74000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 45.22%, operating margin of 13.08%, and the pretax margin is 10.08%.

Becton Dickinson & Co (BDX) Insider Activity

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Becton Dickinson & Co stocks. The insider ownership of Becton Dickinson & Co is 0.17%, while institutional ownership is 90.30%. The most recent insider transaction that took place on Dec 19 ’24, was worth 633,811. In this transaction EVP & President, Medical of this company sold 2,838 shares at a rate of $223.33, taking the stock ownership to the 6,141 shares. Before that another transaction happened on Dec 19 ’24, when Company’s Officer proposed sale 2,838 for $224.09, making the entire transaction worth $635,967.

Becton Dickinson & Co (BDX) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.46 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 9.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.00% during the next five years compared to 8.27% growth over the previous five years of trading.

Becton Dickinson & Co (NYSE: BDX) Trading Performance Indicators

You can see what Becton Dickinson & Co (BDX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.26. Likewise, its price to free cash flow for the trailing twelve months is 21.38.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.94, a number that is poised to hit 2.99 in the next quarter and is forecasted to reach 15.71 in one year’s time.

Technical Analysis of Becton Dickinson & Co (BDX)

Compared to the last year’s volume of 1.49 million, its volume of 1.31 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 58.34%. Additionally, its Average True Range was 4.16.

During the past 100 days, Becton Dickinson & Co’s (BDX) raw stochastic average was set at 29.34%, which indicates a significant decrease from 59.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.22% in the past 14 days, which was lower than the 16.78% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $228.93, while its 200-day Moving Average is $234.06. Nevertheless, the first resistance level for the watch stands at $228.40 in the near term. At $230.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $232.09. If the price goes on to break the first support level at $224.70, it is likely to go to the next support level at $222.89. Should the price break the second support level, the third support level stands at $221.00.

Becton Dickinson & Co (NYSE: BDX) Key Stats

There are 290,008K outstanding shares of the company, which has a market capitalization of 65.69 billion. As of now, sales total 20,178 M while income totals 1,705 M. Its latest quarter income was 5,437 M while its last quarter net income were 400,000 K.